Neogen (NASDAQ:NEOG) Issues Earnings Results, Misses Expectations By $0.06 EPS

Key Points

• Neogen reported quarterly earnings of $0.03 EPS, missing analysts' estimates of $0.09 by $0.06, and had a negative net margin of 53.56%.
• Insider Aashima Gupta bought 16,000 shares at $6.25, raising their total ownership to 21,917 shares, reflecting a 270.41% increase in their position.
• Several hedge funds have recently increased their stakes in Neogen, with institutional investors owning 96.73% of the company's stock.

Neogen (NASDAQ:NEOG - Get Free Report) posted its quarterly earnings results on Tuesday. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.09 by ($0.06), Zacks reports. The company had revenue of $225.46 million during the quarter, compared to analysts' expectations of $222.52 million. Neogen had a negative net margin of 122.06% and a positive return on equity of 2.39%. Neogen updated its FY 2026 guidance to EPS.

Neogen Stock Up 0.2%

Shares of NASDAQ NEOG traded up $0.01 during mid-day trading on Friday, hitting $4.66. The company had a trading volume of 6,055,635 shares, compared to its average volume of 5,337,939. The company has a market capitalization of $1.01 billion, a PE ratio of -0.93 and a beta of 1.77. The company has a debt-to-equity ratio of 0.42, a current ratio of 3.32 and a quick ratio of 2.45. Neogen has a 1-year low of $3.87 and a 1-year high of $17.95. The business's 50-day simple moving average is $5.27 and its 200 day simple moving average is $7.33.

Insider Buying and Selling

In other Neogen news, Director Aashima Gupta bought 16,000 shares of the company's stock in a transaction that occurred on Monday, May 12th. The shares were purchased at an average price of $6.25 per share, with a total value of $100,000.00. Following the completion of the acquisition, the director directly owned 21,917 shares of the company's stock, valued at $136,981.25. This represents a 270.41% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 1.13% of the stock is owned by company insiders.

Hedge Funds Weigh In On Neogen

Large investors have recently bought and sold shares of the business. United Services Automobile Association purchased a new position in shares of Neogen during the first quarter worth about $112,000. Goldman Sachs Group Inc. grew its holdings in shares of Neogen by 14.3% during the first quarter. Goldman Sachs Group Inc. now owns 1,678,493 shares of the company's stock worth $14,553,000 after buying an additional 209,990 shares during the last quarter. Jones Financial Companies Lllp grew its holdings in shares of Neogen by 5,687.3% during the first quarter. Jones Financial Companies Lllp now owns 33,393 shares of the company's stock worth $290,000 after buying an additional 32,816 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Neogen by 4.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 129,813 shares of the company's stock worth $1,125,000 after buying an additional 5,638 shares during the last quarter. Finally, AQR Capital Management LLC grew its holdings in shares of Neogen by 217.0% during the first quarter. AQR Capital Management LLC now owns 52,410 shares of the company's stock worth $443,000 after buying an additional 35,878 shares during the last quarter. Hedge funds and other institutional investors own 96.73% of the company's stock.

Analysts Set New Price Targets

NEOG has been the subject of a number of analyst reports. Guggenheim dropped their price target on Neogen from $13.00 to $10.00 and set a "buy" rating for the company in a research report on Monday, June 30th. William Blair cut Neogen from an "outperform" rating to a "market perform" rating in a report on Tuesday. Finally, Piper Sandler decreased their price target on Neogen from $6.40 to $5.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 22nd.

About Neogen

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.